Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $73.15 | 5 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $45.90 | 3 | $0 (2017) |
| Ambu Inc. | $16.88 | 1 | $0 (2022) |
| Allergan Inc. | $10.37 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $16.88 | 1 | Ambu Inc. ($16.88) |
| 2017 | $56.27 | 4 | Astellas Pharma US Inc ($45.90) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/25/2022 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $16.88 | General |
| 09/11/2017 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $22.31 | General |
| Category: Oncology | ||||||
| 05/22/2017 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: Urology | ||||||
| 02/27/2017 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Urology | ||||||
| 02/02/2017 | Allergan Inc. | BOTOX THERAPEUTIC (Biological) | Food and Beverage | In-kind items and services | $10.37 | General |
| Category: HYPERHYDROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 214 | 243 | $81,129 | $15,100 |
| 2022 | 6 | 234 | 263 | $84,849 | $17,187 |
| 2021 | 8 | 281 | 323 | $87,231 | $20,104 |
| 2020 | 6 | 252 | 278 | $78,153 | $17,110 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 62 | 84 | $23,595 | $5,677 | 24.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 32 | 32 | $12,429 | $2,913 | 23.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 50 | 55 | $10,571 | $2,424 | 22.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 36 | 37 | $26,802 | $2,062 | 7.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 12 | 13 | $5,450 | $1,522 | 27.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 22 | 22 | $2,282 | $502.11 | 22.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 65 | 84 | $22,196 | $5,806 | 26.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 49 | 49 | $17,584 | $4,423 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 56 | 58 | $10,282 | $2,639 | 25.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 39 | 42 | $27,190 | $2,508 | 9.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 13 | 16 | $6,292 | $1,570 | 25.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 12 | 14 | $1,305 | $240.48 | 18.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 53 | 64 | $14,796 | $4,747 | 32.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 46 | 46 | $15,699 | $4,490 | 28.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 80 | 100 | $15,098 | $4,445 | 29.4% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2021 | 37 | 43 | $24,919 | $2,474 | 9.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 13 | 17 | $5,639 | $1,882 | 33.4% |
| 55700 | Biopsy of prostate gland | Facility | 2021 | 12 | 12 | $7,947 | $1,039 | 13.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 28 | 29 | $2,214 | $769.13 | 34.7% |
| 76942 | Ultrasonic guidance imaging supervision and interpretation for insertion of needle | Facility | 2021 | 12 | 12 | $919.00 | $258.92 | 28.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 77 | 91 | $18,558 | $5,190 | 28.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 50 | 50 | $16,614 | $4,798 | 28.9% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Facility | 2020 | 40 | 41 | $21,127 | $2,402 | 11.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 60 | 69 | $9,123 | $2,346 | 25.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 11 | 13 | $3,736 | $1,192 | 31.9% |
About Dr. Robert Schmidt, MD
Dr. Robert Schmidt, MD is a Specialist healthcare provider based in Hillsboro, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1851329783.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Schmidt, MD has received a total of $73.15 in payments from pharmaceutical and medical device companies, with $16.88 received in 2022. These payments were reported across 5 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($73.15).
As a Medicare-enrolled provider, Schmidt has provided services to 981 Medicare beneficiaries, totaling 1,107 services with total Medicare billing of $69,500. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Hillsboro, OR
- Active Since 06/29/2006
- Last Updated 07/08/2007
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1851329783
Products in Payments
- Myrbetriq (Drug) $23.59
- Xtandi (Drug) $22.31
- BOTOX THERAPEUTIC (Biological) $10.37
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Hillsboro
Karen Ogryzlo, Md, MD
Specialist — Payments: $1,302
Linda Moore, Md, MD
Specialist — Payments: $303.12
Todd Sadowski, Md, MD
Specialist — Payments: $64.20
Dr. Aijiro Suzuki, Md, MD
Specialist — Payments: $14.76
Dr. Brooks Cofield, D.o, D.O
Specialist
Lisa Crisi
Specialist